1. Background {#sec1}
=============

In 2017, breast cancer had the highest incidence among female cancers and is still the second (after lung) leading cause of death from cancer in the US \[[@B1]\]. The transition from nonmetastatic to metastatic state of breast cancer is characterised by the diffusion of the primary lesion towards lymphatic sites. Therefore, accurate evaluation of metastasis in axillaries lymphatic nodes is a crucial factor affecting medical management, surgery, and prognosis \[[@B2]--[@B4]\].

Sentinel lymph-node biopsy (SLNB) has been effectively used for identifying, via radiotracer and/or blue dye, the nodes draining the breast which are possibly the first to be encountered during tumor spreading \[[@B5]\]. SLNB is commonly executed after surgical removal of the primary lesion and has shown an accuracy of 93.5 to 97.5% \[[@B6], [@B7]\]. However, it has been noticed that SLNB can have long-term morbidity that potentially can affect the quality of life despite being less significant than axillary lymph-node dissection \[[@B8], [@B9]\]. In addition, preoperative evaluation of axillary lymph nodes might improve patient-based treatment: in fact, options might include neoadjuvant chemotherapy, intraoperative breast radiotherapy, and reconstruction planning. Moreover, when metastatic axillary disease is diagnosed before surgery, the surgeon can discuss specific aspects of axillary lymph-node dissection with the patient.

Despite being not very accurate, imaging techniques such as ultrasound (US), computed tomography (CT), and positron emission tomography (PET)/CT are often used in clinical practice \[[@B10]--[@B13]\]. Breast magnetic resonance imaging (MRI), because of its versatility, has gained a large consensus over the past two decades and many technological improvements have contributed to its diffusion \[[@B12]\]. In particular, dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) has been shown to be able to distinguish benign from malignant breast lesions by means of simultaneous evaluation of morphological and functional information. At the time of writing, axillary lymph nodes evaluation via DCE-MRI has not yet been introduced in clinical practice. Mainly, diagnostic criteria for malignancy of axillary lymph nodes are based exclusively on morphology; however, these are still controversial \[[@B11], [@B14], [@B15]\].

In this study, we investigated the discriminative power of MRI in both morphological and functional features derived by dynamic contrast-enhanced MRI (DCE-MRI) for axillary lymph-node evaluation. We attempted to identify the best quantitative feature to discriminate metastatic from nonmetastatic lymph nodes among 26 morphological and functional parameters and their linear combinations.

2. Methods {#sec2}
==========

2.1. Patients Inclusion Criteria {#sec2.1}
--------------------------------

A prospectively collected database has been reviewed after Institutional Review Board approval. We identified 268 consecutive patients from February 2009 to December 2013 for newly diagnosed breast carcinoma. All these subjects had undergone DCE-MRI in a single cancer centre. The study population comprised 52 patients with breast cancer who also underwent pathological evaluation of axillary lymph nodes. Age ranged from 31 to 58 years. Patients included in the study (1) had breast cancer with clinical evaluation (TNM score) T1-T2 and (2) underwent SLNB or/and axillary lymphadenectomy. Patients who carried an implanted device, were pregnant, or had any contraindication for MRI were not included in the study. In addition, we excluded patients having undergone radiation therapy or chemotherapy within 12 months before the MRI. All patients provided informed consent to the use of their data for research purposes. This retrospective study was performed according to regulations issued by our local Institutional Review Board.

2.2. MRI Methodology {#sec2.2}
--------------------

DCE-MRI has been executed using 1.5 T breast-dedicated equipment (Aurora; Aurora Imaging Technology, North Andover, USA), embodying an in-table coil \[[@B14]\]. Exams were arranged from the 7th to 14th day of the menstrual cycle in premenopausal women; no scheduling limitations were applied in postmenopausal women.

The sequence used for precontrast imaging was a three-dimensional (3D) nonspoiled SPIRAL-RODEO fat-sat (TR 29 ms, TE 4.8 ms, flip angle 45°, matrix 512 × 512, thickness 1.13 mm, and gap 1.13 mm); after contrast injection, four dynamic 3D spoiled SPIRAL-RODEO fat-sat acquisitions (TR 29 ms, TE 4.8 ms, flip angle 45°, matrix 512 × 512, thickness 1.13 mm, and gap 1.13 mm) were used. The time interval between acquisitions was 90 s. A bolus of gadobenate dimeglumine (Multihance, Gd-BOPTA Bracco; Atlanta Pharma, Konstanz, Germany) has been intravenously injected using a dose of 0.1 mmol/kg body weight at a flow rate of 2 ml/s, followed by 20 ml of saline solution at the same rate. An automatic contrast delivery system was employed (Optistar Elite, Covidien Imaging Solution, Hazelwood, USA).

2.3. Histopathological Evaluation and Operation of Axillary Lymph Nodes {#sec2.3}
-----------------------------------------------------------------------

Samples of SLNB were assessed by immediate frozen section and hematoxylin and eosin staining. The nodes were subsequently submitted for permanent sectioning and immunohistochemical assay. According to the American Joint Committee on Cancer guidelines for breast cancer staging \[[@B17]\], a patient with isolated tumor cells was considered node-negative and did not undergo any additional lymph-node surgery.

2.4. Images Analysis {#sec2.4}
--------------------

Two radiologists having more than 15 years of experience (AP) and more than 10 years of experience (SF), respectively, reviewed images. For each lymph node having a lower diameter ≥ 10 mm, the manual segmentation was made using OsiriX v.3.8.1, on the data acquired after contrast injection using a pulse sequence for three-dimensional fat-saturated axial nonspoiled SPIRAL-RODEO images ([Figure 1](#fig1){ref-type="fig"}). Per each lymph node, on each slice, a region of interest (ROI) was drawn: the set of all ROIs corresponding to a single lymph node formed a Volume of Interest (VOI). ROI border has been placed in the lymph-node periphery close to the margin. Lymph nodes were evaluated using quantitative descriptors involving morphological and dynamic parameters.

2.5. Dynamic Parameters {#sec2.5}
-----------------------

Nine dynamic features emerged from the literature \[[@B21]--[@B24]\], which were extracted using the approach previously reported in a previous publication from our group \[[@B23]\] ([Figure 2](#fig2){ref-type="fig"}): maximum signal difference (MSD), the time to peak (TTP) between the wash-in (WI) and wash-out (WO) segments, the WI slope (WIS), the WO slope (WOS), the WI intercept (WII), the WO intercept (WOI), the area under curve (AUC), the area under WI tract (AUCWI), and the area under WO tract (AUCWO).

2.6. Feature Extraction {#sec2.6}
-----------------------

Per each VOI, 17 morphological features were calculated \[[@B18]--[@B20]\]. Before feature computation, all lymph-node binary masks have been reinterpolated on a common grid of equal size (1 × 1 × 1 mm^3^) in three orthogonal directions. A brief description of all morphological features has been provided in [Table 1](#tab1){ref-type="table"}. Detailed mathematical definitions might slightly vary among studies; therefore, we report the specific definitions we used:Circularity = (volume of the sphere with average lymph-node radius)/(lymph-node volume).Compactness = (lymph-node surface area)/(lymph-node volume).Irregularity = 1 -- (surface area of the sphere with average lymph-node radius)/(lymph-node surface area).Diameter = diameter of the sphere corresponding to the lymph-node volume.Rectangularity = (lymph-node volume)/(volume of the smallest parallelepiped containing the lymph node).Radial length = average distance between boundary points and lymph-node barycentre.Volume = number of voxels of the lymph node times the volume of a single voxel.Smoothness = (1/*N*)∑~*n*~*R*~*n*~ − (*R*~*n*−1~ + *R*~*n*+1~)/2, where *Rn* is the *n*th boundary point distance from the barycentre along a lymph-node slice.Curvature = average(abs(*x*′*y*′′--*y*′*x*′′)/(*x*^′2^ +*y*^′2^)^(3/2)^), where *x*,*y* are the coordinate parametric representation of the boundary points along a lymph-node slice,*x*′*y*′ are the first derivative with respect to the parameter, and*x*′′*y*′′ are the second derivative.Roughness: (\[(1/*N*)∑~*n*=1~^*N*^(*R*~*n*~ − *μ*)^4^\]^1/4^ − \[(1/*N*)∑~*n*=1~^*N*^(*R*~*n*~ − *μ*)^2^\]^1/2^)/*μ*, where *N* is the number of points of the boundary, *Rn* is the radial distance of the *n*th point, and *μ* is the average radial distance.Sphericity = (average radial length)/(standard deviation radial length).Eccentricity = (lymph-node largest diameter)/(the largest diameter orthogonal to the previous one).Surface = number of voxels belonging to the lymph-node boundary.Spiculation = standard deviation of radial length.Convexity = (convex-hull volume)/(lymph-node volume);Entropy: −∑~*n*~*P*(*R*~*n*~ = *r*~*n*~)log⁡*P*(*R*~*n*~ = *r*~*n*~), where *P*(*R* = *rn*) is the distribution of radial length.Elongation = (length)/(width) of the smallest rectangle containing the lymph node averaged per each slice in three orthogonal directions.

2.7. Statistical Analysis {#sec2.7}
-------------------------

Histopathological results after surgical intervention served as a reference standard for *N* staging. For each parameter, median and standard deviation (SD) were calculated as representative values of segmented VOI. Interobserver agreement was calculated to assess the variability between two readers in the manual lymph-nodes segmentation. As is commonly reported, an interobserver correlation coefficient of 0--0.20 reflected a poor agreement, of 0.21--0.40 reflected a fair agreement, of 0.41--0.60 reflected a moderate agreement, of 0.61--0.80 reflected a good agreement, and of 0.81--1.00 reflected an excellent agreement. The nonparametric Mann--Whitney test was used to emphasize statistically significant difference between median values of morphological and dynamic parameters in metastatic lymph-nodes group versus nonmetastatic lymph-nodes group. A *P* value of \<0.05 was considered significant for all tests.

Receiver operating characteristic (ROC) analysis in addition to sensitivity, specificity, misclassification error (number of false negatives and false positives over the total), and accuracy (number of true negatives and true positives over the total) has been performed with respect to histopathological results.

Moreover, we applied a linear discriminant analysis (LDA) \[[@B25]\] to identify the best weighted linear combination of features producing the best results considering, respectively, morphological features only, dynamic features only, and both kinds of features together (sensibility and specificity were reported and were considered significant for the features with an accuracy of \>70% at ROC analysis). 10-fold cross-validation has been performed in order to have robust result \[[@B25]\].

Statistical processing and classification have been performed by means of the Statistics Toolbox within Matlab R2007a (MathWorks Inc., Natick, USA).

3. Results {#sec3}
==========

In the present study, 94 dominant lymph nodes were evaluated in 52 patients with primary breast carcinoma: 48 metastatic lymph nodes and 46 not pathological lymph nodes.

[Table 2](#tab2){ref-type="table"} reports median and standard deviation for each morphological parameter in the metastatic lymph-nodes group versus the nonmetastatic lymph-nodes group. The median of all the parameters, except circularity, showed a statistically significant difference between the two groups.

[Table 3](#tab3){ref-type="table"} reports median and standard deviation for each dynamic parameter in the metastatic lymph-nodes group versus the nonmetastatic lymph-nodes group. The median of all parameters, except MSD and WOS, showed a statistically significant difference between the two groups.

Interobserver correlation coefficient calculated on VOI for each segmented lymph node was of 0.864 (95% CI: 0.835--0.884) indicating an excellent agreement between the two manual segmentations; in addition, this indicates the robustness of morphological and dynamic parameters calculated on segmented lymph nodes.

[Table 4](#tab4){ref-type="table"} reports findings of ROC analysis for each morphological and dynamic parameter in terms of sensitivity, specificity, misclassification error, and accuracy. The best discrimination between metastatic lymph nodes and nonmetastatic lymph nodes has been obtained by AUC, WIS, WOS, and AUCWO of the dynamic features and by compactness, curvature, radial length, roughness, smoothness, and speculation of the morphological features.

[Table 5](#tab5){ref-type="table"} reports the finding of LDA analysis when all morphological and dynamic features were considered and when the linear combination of significant morphological and dynamic features was considered.

4. Discussion {#sec4}
=============

Histopathologic staging of axillary lymph node is one of the most commonly used predictors of breast cancer survival. Currently, diagnosis of metastatic involvement requires invasive procedures such as pathologic assessment of biopsy tissue or postsurgery dissection. Conventional MRI with double breast coils can noninvasively evaluate both breasts and simultaneously assess axillary lymph nodes; moreover, new techniques, such as DCE-MRI, are now achieving a sufficient degree of maturity for breast cancer evaluation. The verification of MRI-based diagnoses of a specific node with histopathologic analysis of the same node is still a challenge. Moreover, the use of DCE-MRI for assessment of metastatic axillary lymph nodes has not yet been sufficiently investigated and conflicting results until now have been published \[[@B26]--[@B33]\]. In this study, we used several morphological features and several dynamic MRI characteristics of axillary lymph nodes. We investigated whether and how malignant nodes could be assessed preoperatively and noninvasively by means of MRI using both morphologic and dynamic criteria. The sensitivity of these features ranged from 28.6% to 92.9%, and the specificity ranged from 34.6% to 81.3%. The best results for discrimination of nonmetastatic lymph nodes by metastatic lymph nodes have been achieved by AUC, WIS, WOS, and AUCWO, among the dynamic features, and by compactness, curvature, radial length, roughness, smoothness, and speculation, among morphological features. The best dynamic parameter was AUC reporting a sensitivity, specificity, misclassification error, and accuracy of 81%, 72%, 24%, and 76%, respectively. The best morphological parameter was compactness reporting a sensitivity, specificity, misclassification error, and accuracy of 83%, 81%, 18%, and 82%, respectively.

Our results are similar to those of other researchers \[[@B26]--[@B30]\]. Choi et al. \[[@B26]\] performed a meta-analysis reporting the diagnostic performance of CT, MRI, and PET/CT for detection of metastatic lymph nodes in cervical cancer patients: for region- and node-based data analysis, MRI sensitivity and specificity were 38% and 97%, respectively. He et al. \[[@B27]\] and Baltzer et al. \[[@B28]\] investigated diagnostic performance of specific morphological and/or dynamic features obtained by MR imaging. He et al. reported the area under ROC (AUROC) for short and long lymph-node axis of 0.89 and 0.74, respectively (sensitivity of 93.3% and specificity of 72.6% for short axis, sensitivity of 88.1% and specificity of 64.1% for long axis) and the AUROC of early stage enhancement rate as a dynamic feature (sensitivity of 97.0% and specificity of 73.5%). Baltzer et al. \[[@B28]\] investigated only the margin of lymph nodes as a morphological parameter reporting a sensitivity of 41.2% and a specificity of 95.2%. Schacht et al. \[[@B29]\] reported the results of a quantitative breast MR image analysis for classification of axillary lymph nodes. The best features in that study were the circularity as a morphological parameter with AUROC of 0.67 and the wash-out rate with AUROC of 0.62. Harada et al. \[[@B30]\] evaluated the diagnostic performance of morphologic features computable from MR images using a contrast agent actually not commercialized (ultrasmall superparamagnetic iron oxide): sensitivity, specificity, and overall accuracy were 36.5%, 94.1%, and 81%, respectively.

On the basis of our results, a linear combination of morphological and dynamic feature does not increase the accuracy in lymph-nodes discrimination. LDA results of each group and combination of groups (morphological and/or dynamic parameters) were comparable to results of dynamic and morphological parameters considered separately. A future endpoint could be to perform multivariate analysis of functional parameters including other modalities such as PET/CT examination or quantitative parameters derived by hybrid system like PET/MRI \[[@B34]\].

A limit of our study consists of the manual segmentation of lymph nodes. However, an expert breast radiologist performed this procedure. A second limitation is the level of complexity in the "gold standard" due to the difficult task of identifying which lymph nodes were biopsied or dissected and of matching the pathologic results to the imaged nodes.
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![Lymph-node illustration on contrast-enhanced MR imaging and their segmentation for a single slice: (a)--(c) grey level; (b)--(d) RGB values.](BMRI2018-2610801.001){#fig1}
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###### 

List of features used in analysis with definitions.

  Feature category   Feature                                                                                               Description
  ------------------ ----------------------------------------------------------------------------------------------------- --------------------------------------------
  Dynamic            TTP                                                                                                   Time to peak
  MSD                Maximum signal difference                                                                             
  AUGC               Area under gadolinium curve                                                                           
  AUCWI              Area under gadolinium curve in the wash-in phase                                                      
  AUCWO              Area under gadolinium curve in the wash-out phase                                                     
  WIS                Wash-in slope                                                                                         
  WII                Wash-in intercept                                                                                     
  WOS                Wash-out slope                                                                                        
  WOI                Wash-out intercept                                                                                    
                                                                                                                           
  Morphological      circularity                                                                                           Similarity of the lesion shape to a sphere
  compactness        Ratio between surface and volume                                                                      
  convexity          Ratio between the smallest volume with convex curvature that contains the lymph node and its volume   
  curvature          Measure of curvature of lymph node contour                                                            
  elongation         Parameter that estimates how much the ROI is pronounced along one direction than along the other      
  diameter           Diameter of the sphere having the same ROI volume                                                     
  eccentricity       Ratio of the larger rope and the largest among the orthogonal ropes                                   
  irregularity       Deviation of the lesion surface from the surface of a sphere                                          
  radial length      Average distance between points on the border and the center of the lymph node                        
  entropy            Entropy of radial length                                                                              
  rectangularity     Similarity of the lesion shape to a rectangle                                                         
  roughness          Distances of each point of the center than the radial length average                                  
  smoothness         Measurement of lymph node contour irregularities                                                      
  sphericity         Ratio between the average radial length and the standard deviation of the rays                        
  spiculation        Standard deviation of the radial lengths with respect to the radial length average                    
  surface            Sum of lymph nodes contour pixels                                                                     
  volume             Volume of the entire lymph node                                                                       

###### 

Morphological features median and standard deviation values for each parameter. *P* value was calculated using Mann--Whitney test.

  Morphological Features   Metastatic   Non Metastatic   *P* value              
  ------------------------ ------------ ---------------- ----------- ---------- -------
  circularity              0,001        0,002            0,002       0,003      0,829
  compactness              0,339        0,125            0,453       0,076      0,021
  Convexity                0,824        0,133            0,857       0,159      0,005
  curvature                0,091        0,038            0,133       0,052      0,001
  Elongation               1,133        0,307            1,281       0,430      0,000
  diameter                 17,812       7,891            14,392      3,278      0,000
  eccentricity             1,658        0,584            1,679       0,678      0,000
  Irregularity             −3,487       0,562            −3,425      0,760      0,000
  radial length            0,929        0,031            0,960       0,020      0,000
  Entropy                  4,763        0,214            4,664       0,241      0,000
  rectangularity           0,358        0,071            0,332       0,092      0,000
  Roughness                0,353        0,232            0,102       0,078      0,000
  smoothness               4,283        1,914            3,320       0,539      0,000
  sphericity/roundness     26,372       15,870           41,890      27,259     0,000
  Spiculation              6,602        2,656            4,323       1,369      0,000
  Surface                  1094,000     1207,675         698,000     540,839    0,000
  volume                   2959,000     7956,682         1561,000    1114,509   0,000

###### 

Dynamic features median and standard deviation values for each parameter. *P* value was calculated using Mann--Whitney test.

  Features   Metastatic Lymph-nodes   Non Metastatic Lymph-nodes   *P* value              
  ---------- ------------------------ ---------------------------- ----------- ---------- -------
  MSD        1079,000                 641,773                      597,500     474,324    1,000
  TTP        372,261                  169,279                      459,888     179,981    0,021
  AUC        3,000                    1,193                        3,000       0,994      0,003
  WII        1,453                    0,215                        1,521       0,198      0,001
  WOI        11475,000                3002,216                     8871,375    2198,225   0,000
  WIS        1924,637                 819,422                      2005,110    668,567    0,037
  WOS        1384,000                 535,408                      1442,450    486,190    0,214
  AUCWI      395,952                  174,820                      468,695     179,586    0,002
  AUCWO      2951,250                 1549,637                     3654,000    1280,761   0,000

###### 

ROC analysis findings for each morphological and dynamic parameter in terms of sensitivity, specificity, misclassification error, and accuracy.

  Features               Sensitivity \[%\]   Specificity \[%\]   Misclassification Error \[%\]   Accuracy \[%\]   AUC
  ---------------------- ------------------- ------------------- ------------------------------- ---------------- ---------
  MSD                    73,910              64,100              32,260                          67,740           0.668
  TTP                    38,890              34,620              62,900                          37,100           0.516
  AUC                    80,770              72,220              24,190                          *75,810*         *0.769*
  WII                    40,000              43,240              58,060                          41,940           0.501
  WOI                    44,830              45,450              54,840                          45,160           0.437
  WIS                    78,260              66,670              29,030                          *70,970*         *0.717*
  WOS                    70,970              70,970              29,030                          *70,970*         *0.657*
  AUCWI                  28,570              39,020              64,520                          35,480           0.459
  AUCWO                  81,820              67,500              27,420                          *72,580*         *0.766*
  Circularity            60,980              71,430              35,480                          64,520           0.762
  Compactness            83,330              81,250              17,740                          *82,260*         *0.824*
  Convexity              42,420              41,380              58,060                          41,940           0.469
  Curvature              68,570              74,070              29,030                          *70,970*         *0.770*
  Elongation             57,890              62,500              40,320                          59,680           0.680
  Diameter               69,230              63,890              33,870                          66,130           0.738
  Eccentricity           52,630              54,170              46,770                          53,230           0.453
  Irregularity           54,550              55,170              45,160                          54,840           0.448
  Radial Length          76,000              67,570              29,030                          *70,970*         *0.811*
  Entropy                62,500              72,730              33,870                          66,130           0.699
  Rectangularity         56,670              56,250              43,550                          56,450           0.564
  Roughness              85,710              68,290              25,810                          *74,190*         *0.834*
  Smoothness             90,480              70,730              22,580                          *77,420*         *0.810*
  Sphericity/roundness   62,790              78,950              32,260                          67,740           0.710
  Spiculation            81,820              67,500              27,420                          *72,580*         *0.742*
  Surface                68,180              60,000              37,100                          62,900           0.713
  Volume                 92,860              62,500              30,650                          69,350           0.738

###### 

LDA analysis findings when all morphological and dynamic features were considered and when the linear combinations of significant morphological and dynamic features were considered.

                                         Sensitivity \[%\]   Specificity \[%\]   AUC
  -------------------------------------- ------------------- ------------------- -------
  All dynamic features                   77,420              70,970              0.778
  All morphological features             70,970              80,650              0.803
  All features                           64,520              77,400              0.754
  All significant dynamic features       85,000              66,700              0.794
  All significant morphologic features   88,500              77,800              0.812
  All significant features               81,000              65,900              0.789
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